Interstitial
administration (e.g., subcutaneous (SC) administration)
of immunotherapies and vaccines within nanoparticles can improve access
to lymph-resident immune cells, leading to enhanced efficacy and reduced
off-target effects. Recently, endogenous high-density lipoproteins
(HDLs) were found to return from peripheral tissue back to the systemic
circulation via the lymphatic vessels and nodes. This suggests the
potential utility of HDLs as biocompatible lymphatic-targeted therapeutic
carriers. However, we have a limited understanding of the mechanisms
that drive HDL uptake into peripheral lymphatics from the interstitium.
This study investigated the influence of HDL physicochemical properties
on lymphatic transport and lymph node (LN) retention of HDL after
SC administration. A range of HDL particles was prepared and characterized.
Sphere-shaped endogenous HDLs were isolated from biological fluids
(rat lymph, rat plasma, and human plasma) and separated into two subclasses
based on the density. Discoidal-shaped synthetic (reconstituted) HDLs
(rHDLs) of similar sizes were assembled from lipids and apolipoprotein
A-I. All HDLs had similar sizes of 10–20 nm and a slightly
negative surface charge. All HDLs were radiolabeled with 3H-cholesteryl ester (3H-CE) and/or 14C-free
cholesterol (14C FC) and administered SC into the hind
leg of thoracic lymph-cannulated rats. The recovery of radiolabels
in lymph, plasma, LN, and tissues was determined. From the interstitial
injection site, all HDLs were preferentially transported into the
lymph and not blood vessels as indicated by high lymph-to-plasma concentration
ratios of the radiolabels (up to 100:1 during the absorption phase)
and greater radiolabel recovery in LNs draining the injection site
compared to the contralateral side. Several HDLs with unique composition
demonstrated significantly higher lymphatic transport compared to
other HDLs despite possessing similar physical properties, suggesting
that HDL lymphatic transport is less influenced by physical properties.
The LN retention of HDL was positively correlated to increasing the
negative charge of HDL, which was related to surface composition.
Overall, this study informs the optimal design of HDL-based nanoparticles
to promote lymphatic targeting of immunotherapies and vaccines.